Abstract | BACKGROUND AND AIMS: MATERIAL AND METHODS: A comprehensive literature search was conducted for the following terms, alone or in combination: allergic rhinitis, asthma, antihistamines, histamine, and histamine receptors, and for the second-generation antihistamines azelastine, cetirizine, desloratadine, ebastine, fexofenadine, levocetirizine, loratadine, mizolastine, and rupatadine. Clinical trials were included that reported results for patients with AR and comorbid asthma who were treated with second-generation antihistamines. The search dates ranged from 1995 through 2010. Clinical studies that were not placebo controlled or double blinded were excluded from this review. RESULTS: A total of 14 clinical trials of second-generation nonsedating antihistamines were included in this review. CONCLUSION: H1-antihistamines have been shown to attenuate the symptoms associated with early- and late-phase allergic reactions. Cumulative clinical evidence indicates that H1-antihistamines may have a beneficial effect on asthma symptoms and improve quality of life. Scientific significance. Mechanistic and clinical data suggest that the potential of H1-antihistamines to alleviate comorbid asthma symptoms in AR patients should be further investigated.
|
Authors | Claus Bachert, Jorge Maspero |
Journal | The Journal of asthma : official journal of the Association for the Care of Asthma
(J Asthma)
Vol. 48
Issue 9
Pg. 965-73
(Nov 2011)
ISSN: 1532-4303 [Electronic] England |
PMID | 21970671
(Publication Type: Journal Article, Review)
|
Chemical References |
- Histamine H1 Antagonists, Non-Sedating
- Receptors, Histamine
|
Topics |
- Asthma
(complications, drug therapy, physiopathology)
- Histamine H1 Antagonists, Non-Sedating
(therapeutic use)
- Humans
- Receptors, Histamine
(physiology)
- Rhinitis, Allergic, Perennial
(complications, drug therapy, physiopathology)
- Rhinitis, Allergic, Seasonal
(complications, drug therapy, physiopathology)
|